Go to main website
Sensus Healthcare - Logo

Press Releases

Sensus Healthcare Announces Study Showing Single Low Dose of Superficial Radiation Therapy Prevents Keloid Recurrence Following Surgical Excision

Prospective study published in Journal of the American Academy of Dermatology BOCA RATON, Dec. 01, 2020 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces the publication of a prospective clinical study showing that a single low dose of […]
READ MORE

Sensus Healthcare Reports Third Quarter 2020 Financial Results

Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Nov. 05, 2020 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial results for the three and nine months ended September 30, 2020. Highlights from the […]
READ MORE

Sensus Healthcare Appoints Megan Cornish to its Board of Directors

Gains valuable Capitol Hill, business strategy and marketing experience BOCA RATON, Fla, Nov. 05, 2020 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces the appointment of Megan Cornish to its board of directors, effective January 1, 2021. Ms. […]
READ MORE

Sensus Healthcare to Host Third Quarter 2020 Financial Results and Business Update Conference Call on November 5, 2020

BOCA RATON, Fla. , Oct. 29, 2020 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, November 5, 2020 at 4:30 p.m. Eastern time to discuss the financial results for the third […]
READ MORE

Sensus Healthcare Announces Publication of Study Showing Use of Superficial Radiation Therapy Post-Keloidectomy Prevents Keloid Recurrence

Keloid recurrence rate of 10.4% at 12 months for patients treated with SRT following keloidectomy compares with more than 80% with surgical excision alone Retrospective study published in Journal of Clinical and Aesthetic Dermatology BOCA RATON, Fla., Oct. 22, 2020 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, […]
READ MORE

Sensus Healthcare Reports Second Quarter 2020 Financial Results

Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Aug. 06, 2020 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial results for the three and six months ended June 30, 2020. Highlights from the […]
READ MORE

Get notified about Sensus Healthcare

Get Email Alerts
Sensus Healthcare - Logo - Footer
Sensus Healthcare partners with The Pinnacle Health Group to provide reimbursement support for all customers. Please contact Pinnacle for support by phone at 866-369-9290 or email at [email protected] Hotline consultants are available Monday through Friday from 8:30 AM to 6:00 PM EST.
Contact Us
Sensus Healthcare World Headquarters:

851 Broken Sound Parkway
Boca Raton, FL 33487
[email protected]

Phone 561.922.5808
Toll-free 800.324.9890
Fax 561.948.2071
© Copyright 2023. Sensus Healthcare - All Rights Reserved.